← Eichor
Study identifier: NCT06966752 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparison of Continuous Positive Airway Pressure (CPAP) and Non-Invasive Positive Pressure Ventilation (NIPPV) in Preterm Newborns With Respiratory Distress Syndrome.

Condition: Respiratory Distress Syndrome (RDS)  ·  Sponsor: Vilnius University

PhaseNA
Planned participants150
Who can joinAll sexes, 0 Minutes to 44 Weeks
Healthy volunteersNo

About this study

Primary objective: to evaluate safety and efficacy of two different non-invasive respiratory support modalities in preterm neonatal patients with respiratory distress syndrome. Secondary objective is to compare different respiratory support mode performance in different gestational age groups. Primary endpoint is treatment failure. With this study, the following hypotheses will be tested: Hypothesis 1: NIPPV has a lower failure rate compared to CPAP mode. Hypothesis 2: NIPPV complication rate is non-superior compared to CPAP.

This description comes directly from the study's public registry record.

Talk to the study team

Arunas Liubsys, Associate Professor  ·  +370 6 872 2520  ·  arunas.liubsys@santa.lt

Ernestas Virsilas  ·  +37060787438  ·  ernestas.virsilas@santa.lt

Always discuss trial participation with your own doctor first.

Locations (1)

Vilnius University Santaros KlinikosVilnius, Vilnius County, LithuaniaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06966752